Alessio Paternòa,
Francesca D'Annab,
Giuseppe Musumarra*a,
Renato Notob and
Salvatore Scirèa
aDipartimento di Scienze Chimiche, Università di Catania, Viale A. Doria 6, 95125 Catania, Italy. E-mail: gmusumarra@unict.it
bDipartimento STEBICEF, Università di Palermo, Viale delle Scienze-Parco d'Orleans II, Ed.17, 90128 Palermo, Italy
First published on 21st May 2014
A multivariate insight into Ionic Liquids' (ILs) toxicity, a broad term highly dependent on the biological systems adopted as “sensors”, addressed four main groups of toxicities: aquatic toxicity, toxicity towards fungi and bacteria, cytotoxicity towards IPC-81 rat cell lines and acetylcholinesterase enzyme inhibition. This approach, summarizing toxicity information available from a huge amount of scattered literature data, allowed derivation of aquatic toxicity scores for 104 ILs and bacteria and fungi toxicity scores for 87 ILs as well as identification of a correlation between aquatic ecotoxicity and the response of IPC-81 rat cell lines. Further evidence on the effects of cation structural features such as the increase of IL toxicity on increasing the length of the side chain and its decrease when oxygen atoms are present in the side chain was obtained. Maximum dialkyloxyether imidazolium toxicity was observed for ILs having 7–9 carbon atoms in each side chain, while toxicity decreased for ILs with a higher number of carbons, probably due to the formation of micellar aggregates.
The increasing number of IL applications as reaction media,1–4 catalysts,5–8 lubricants,9 surfactants,10 anticorrosion agents,11,12 in separation science,13–16 and more in general in analytical chemistry,17 prompted several investigations on the hazard potential of ILs in different biological test systems. Indeed, their water solubility poses the danger of their release and consequently the exertion of negative effects in aquatic ecosystems. On the other hand, high chemical and thermal stability highlights the problem of their bioaccumulation, making the proper assessment of the ionic liquids' toxicological profile a problem of major concern.18
The broad number of combinations of cations and anions determines the chemical properties of ILs as well as their toxicity. Several studies agree that ecotoxicity increases on increasing the side chain hydrophobicity, however many other structural effects may influence eco-sustainability and toxicity. Each of the many publications aimed at the assessment of ILs' impact on human health and the environment includes different structures and different aquatic, terrestrial and cell line models.
Frade and Afonso,18 who recently provided an overview on the impact of ILs on the environment and on humans, summarized toxicological data for a large number of ILs performed in models of different origin: aquatic toxicity, terrestrial toxicity and toxicological assays aimed at evaluating the impact on humans. This study18 indicated as a future challenge in the field “to extend the study on aquatic and terrestrial environment to other cations” and “to know whether likely negative impact on water and soil were caused by the same structures as the ones that were showed to be harsher to human and rat cell lines”.
Toxicity data reported in the growing number of studies analyzing the hazard potential for many ionic liquids in different biological test systems were collected and are steadily updated in a precious database: the UFT-Merck Ionic Liquids Biological Effects Database.19 The database includes several assays at different levels of biological organization and complexity. These data confirm that ILs have a large “green” potential, but recent studies show that ILs may reveal a low or a high hazard and that the “greenness” strongly depends on the structure.19
Despite the explosion of ILs applications requires urgently the assessment of their impact on human's health and environment, each of the available studies investigates different structures and different biological models and an overall picture of ILs toxicity is not available. However, toxicity is a very broad term and tests towards cells and living organism highly depend on the nature of biological systems. Several biological “sensors” have been reported as representative of the hazard of ionic liquids, but a recent review20 points out that available investigations regarding cytotoxicity, toxicity towards invertebrates, vertebrates, fungi and bacteria, phytotoxicity, impact on enzymatic activity and protein stability, provide no simple and uniform picture. Although each “sensor” can be considered as representative of a potential hazard, it is not always available for a wide number of ILs, its determination is affected by specific measurement errors and furthermore different “sensors” can be related to each other providing similar information content. A multivariate approach such as Principal Component Analysis (PCA), applied here for the first time to a data matrix containing experimental measurements of toxicity “sensors” (variables) for a series of ILs (objects), can provide a simplified picture on ILs toxicity. In fact, PCA scores can be determined for a larger set of objects (ILs) with respect to those available for single observables (“sensors”), are affected by lower error as compared to those of single determinations, and summarize the information content into a reduced number of variables (toxicity scales).
In this context aim of the present work is to exploit the potential of multivariate analysis to extract maximum information from the huge amount of scattered available data, herein grouped according to four main kinds of toxicities: (1) aquatic toxicity; (2) toxicity towards fungi and bacteria; (3) cytotoxicity towards IPC-81 rat cell lines; (4) acetyl cholinesterase enzyme inhibition, and to gain a better knowledge on the relationships among them.
The loadings plot in the above overall model (Fig. 2) shows also that the 1st PC separates AChE and IPC-81 from all other biological tests, while the 2nd PC is required to discriminate the above two variables. The above finding cannot exclusively be ascribed to their different information content (i.e. they are not representative of ecotoxicity) as the model is somewhat “driven” by the great information content provided by a large number of data for two variables (232 for AChE and 245 for IPC-81) as compared to that of all other variables. This bioinformatics finding has also a rational biological explanation as AChE and IPC-81, biological tests aimed at evaluating toxicity towards more complex living organisms, are expected to have a different information content with respect to the other examined variables. Consequently in order to have a better insight on the influence of the latter variables on ILs ecotoxicity, AChE and IPC-81 were excluded in further PCA analysis and will be considered separately. PCA could not be carried out on a reduced data matrix including both aquatic ecotoxicities and toxicity towards fungi and bacteria as both toxicity data are not available for most ILs, probably due to different hydrophilic/hydrophobic properties which prevent their determination in both systems. Therefore separate PCA models had to be derived for aquatic ecotoxicity and toxicity towards fungi and bacteria.
CAS no. | Name | t1 aquatic toxicity model | IPC-81 ranka | AChE rankb | |
---|---|---|---|---|---|
a In a list for 245 ILs ordered according to decreasing log(IPC-81) values.b In a list for 232 ILs ordered according to decreasing log(AChE) values. | |||||
1 | 174899-81-1 | 1,3-Dimethylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 3.91 | ||
2 | 827027-30-5 | 1-(3-Hydroxypropyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 3.24 | 61 | 22 |
3 | 342573-75-5 | 1-Ethyl-3-methylimidazolium ethyl sulfate | 3.21 | 57 | 117 |
4 | 75174-77-5 | 4-Butyl-4-methylmorpholinium bromide | 3.18 | 17 | 50 |
5 | None (2013-09-19) | 1-Methyl-1-propylpiperidinium hexafluorophosphate | 2.90 | ||
6 | 216300-12-8 | 1-Methyl-3-propylimidazolium hexafluorophosphate | 2.89 | 155 | 88 |
7 | 937720-90-6 | 1-(Cyanomethyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 2.73 | 36 | 14 |
8 | 355011-34-6 | 1-(3-Hydroxypropyl)-3-methylimidazolium chloride | 2.62 | 28 | 33 |
9 | 342789-81-5 | 1-Butyl-3-methylimidazolium methanesulfonate | 2.61 | 101 | 138 |
10 | 94280-72-5 | 1-Butyl-1-methylpiperidinium bromide | 2.44 | 46 | 171 |
11 | 945996-02-1 | 1-(Ethoxymethyl)-3-methylimidazolium chloride | 2.38 | 104 | 65 |
12 | 1012794-00-1 | 1-(2-Hydroxyethyl)-3-methylimidazolium iodide | 2.15 | 15 | 21 |
13 | 410522-18-8 | 1-Butyl-3-methylimidazolium 4-methylbenzenesulfonate | 2.01 | 118 | 112 |
14 | 448245-52-1 | 1-Butyl-3-methylimidazolium N-cyanocyanamide | 1.97 | 152 | 166 |
15 | 85100-77-2 | 1-Butyl-3-methylimidazolium bromide | 1.92 | 121 | 152 |
16 | 608140-12-1 | 1-Methyl-1-propylpiperidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.78 | 119 | |
17 | 154312-63-7 | 1-(Cyanomethyl)-3-methylimidazolium chloride | 1.54 | 38 | 49 |
18 | 874-80-6 | 1-Butylpyridinium bromide | 1.44 | 67 | 181 |
19 | 324574-95-0 | 4-Butyl-4-methylmorpholinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.44 | 80 | 17 |
20 | 1012794-06-7 | 1-(3-Methoxypropyl)-3-methylimidazolium chloride | 1.38 | 9 | 63 |
21 | 827027-29-2 | 1-(3-Hydroxypropyl)pyridinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.33 | 73 | 40 |
22 | None (2013-09-19) | 1-Methyl-3-(2-methylpropyl)imidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.32 | ||
23 | 1015254-36-0 | 1-(3-Methoxypropyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.29 | 88 | 35 |
24 | 216299-72-8 | 1-Methyl-3-propylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.25 | ||
25 | 460983-97-5 | 1-Hexylpyridinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.25 | 144 | 109 |
26 | 1332694-08-2 | 1-(3-Hydroxypropyl)-1-methylpyrrolidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.22 | 68 | 19 |
27 | 1241842-94-3 | 1-[1-(1,3-Benzodioxol-5-yl)-2-methoxy-2-oxoethyl]pyridinium bromide | 1.22 | ||
28 | 1049751-90-7 | 4-(Ethoxymethyl)-4-methylmorpholinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.22 | 82 | 11 |
29 | 827033-71-6 | 1-Butylpyridinium N-cyanocyanamide | 1.21 | ||
30 | 479500-35-1 | 1-Butyl-1-methylpyrrolidinium chloride | 1.11 | 26 | 175 |
31 | 174899-88-8 | 1,3-Diethylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 1.04 | ||
32 | 129412-64-2 | 1-(2-Ethoxy-2-oxoethyl)-1-methylpyrrolidinium bromide | 1.03 | 66 | |
33 | 65039-09-0 | 1-Ethyl-3-methylimidazolium chloride | 1.00 | 74 | 164 |
34 | 623580-02-9 | 1-Butyl-1-methylpiperidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.97 | 84 | 122 |
35 | 244193-49-5 | 1-Methyl-3-pentylimidazolium tetrafluoroborate | 0.94 | 162 | 167 |
36 | 244193-48-4 | 1-Methyl-3-propylimidazolium tetrafluoroborate | 0.92 | 117 | 93 |
37 | 474972-46-8 | 1-(2-Methoxyethyl)-3-methylimidazolium chloride | 0.88 | 27 | 68 |
38 | 174899-82-2 | 1-Ethyl-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.87 | 95 | 90 |
39 | 1012793-99-5 | 1-(2-Ethoxyethyl)-3-methylimidazolium bromide | 0.77 | 34 | 89 |
40 | 178631-01-1 | 1-(2-Methoxyethyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.73 | 102 | 46 |
41 | 65039-05-6 | 1-Butyl-3-methylimidazolium iodide | 0.64 | 97 | 118 |
42 | 370865-89-7 | 1-Ethyl-3-methylimidazolium N-cyanocyanamide | 0.60 | 81 | 74 |
43 | 1107545-20-9 | 1-(2-Ethoxy-2-oxoethyl)-1-methylpyrrolidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.49 | 64 | 5 |
44 | 742099-80-5 | 1-Ethyl-3-methylimidazolium tetracyanoborate | 0.46 | 103 | 144 |
45 | 945996-13-4 | 1-(Ethoxymethyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.46 | 108 | 51 |
46 | 757240-24-7 | 1-(2-Methoxyethyl)-1-methylpyrrolidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.31 | 93 | 79 |
47 | 79917-90-1 | 1-Butyl-3-methylimidazolium chloride | 0.27 | 114 | 176 |
48 | 666823-18-3 | 1-Ethyl-3-methylimidazolium, salt with methanetricarbonitrile (1![]() ![]() |
0.24 | 140 | 67 |
49 | 67226-45-3 | 1-Butylpyridinium μ-chlorohexachlorodialuminate | 0.23 | 71 | 150 |
50 | None (2013-09-19) | 1-Butyl-3-methylimidazolium hexafluorophosphate | 0.21 | 143 | 94 |
51 | 26576-85-2 | 1-Butyl-3-methylpyridinium bromide | 0.21 | ||
52 | 1049751-95-2 | 1-(3-Methoxypropyl)-1-methylpiperidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.21 | 94 | 62 |
53 | 663628-46-4 | 1-(2-Ethoxyethyl)-1-methylpyrrolidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.18 | 106 | 39 |
54 | 244193-50-8 | 1-Hexyl-3-methylimidazolium tetrafluoroborate | 0.15 | 161 | 156 |
55 | 26576-98-7 | 1-Butyl-3,5-dimethylpyridinium bromide | 0.13 | ||
56 | 1124-64-7 | 1-Butylpyridinium chloride | 0.09 | 189 | |
57 | 174899-83-3 | 1-Butyl-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | 0.02 | 170 | 95 |
58 | 712355-12-9 | 1-Butyl-3-methylpyridinium N-cyanocyanamide | −0.04 | 115 | 208 |
59 | 174501-65-6 | 1-Butyl-3-methylimidazolium tetrafluoroborate | −0.06 | 151 | 143 |
60 | 710336-91-7 | 1-Butyl-3-methylimidazolium 1,1,1-trifluoro-N-(trifluoromethyl)methanaminate | −0.06 | 201 | 183 |
61 | 343952-33-0 | 1-Butyl-4-methylpyridinium tetrafluoroborate | −0.07 | 163 | 190 |
62 | 1241842-26-1 | 1-[1-(1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]-3-methylimidazolium bromide | −0.08 | ||
63 | 350493-08-2 | 1-Butyl-2,3-dimethylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −0.16 | ||
64 | 174899-66-2 | 1-Butyl-3-methylimidazolium trifluoromethanesulfonate | −0.19 | 148 | 131 |
65 | 347882-21-7 | 1-Ethyl-3-propylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −0.20 | ||
66 | 852616-00-3 | 1-Ethyl-3-methylimidazolium bis(pentafluoroethyl)phosphinate | −0.21 | 154 | 83 |
67 | 697248-62-7 | 1-Hexyl-3-methylimidazolium, salt with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1![]() ![]() |
−0.28 | 193 | 108 |
68 | 778593-17-2 | 1-(2-Ethoxyethyl)-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −0.28 | 72 | 76 |
69 | 1424967-13-4 | 1-[1-(1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethyl]pyridinium bromide | −0.41 | ||
70 | 380497-19-8 | 1-Hexyl-1-methylpyrrolidinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −0.48 | 177 | 30 |
71 | 1241840-01-6 | 1-[1-(3,4-Dimethoxyphenyl)-2-methoxy-2-oxoethyl]pyridinium chloride | −0.49 | ||
72 | 877678-54-1 | 1-Butyl-3,5-dimethylpyridinium N-cyanocyanamide | −0.54 | ||
73 | 244193-51-9 | 1-Heptyl-3-methylimidazolium tetrafluoroborate | −0.66 | 184 | 101 |
74 | 1241842-81-8 | 1-[1-(1,3-Benzodioxol-5-yl)-2-methoxy-2-oxoethyl]-3-methylimidazolium chloride | −0.69 | ||
75 | 749921-07-1 | 1,3-Dibutylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −0.71 | ||
76 | 445473-58-5 | 1-Butyl-3-methylimidazolium octylsulfate | −0.89 | 120 | 103 |
77 | 393550-29-3 | 1-Ethyl-3-hexylimidazolium tetrafluoroborate | −1.00 | 200 | 158 |
78 | 376650-04-3 | 1-Ethyl-3-methylimidazolium bis[1,2-benzenediolato(2-)-O1,O2]borate | −1.06 | 231 | 92 |
79 | 67021-56-1 | 1-Hexyl-3-methylpyridinium bromide | −1.08 | ||
80 | 280779-53-5 | 1-Methyl-3-pentylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −1.16 | ||
81 | None (2013-09-19) | 1,3-Dipropylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −1.21 | ||
82 | None (2013-09-19) | 1,3-Dihexylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −1.21 | ||
83 | 474972-49-1 | 1-[2-(2-Methoxyethoxy)ethyl]-3-methylimidazolium chloride | −1.42 | ||
84 | 304680-35-1 | 1-Hexyl-3-methylimidazolium hexafluorophosphate | −1.54 | 159 | 136 |
85 | 171058-17-6 | 1-Hexyl-3-methylimidazolium chloride | −1.57 | 180 | 169 |
86 | 872672-57-6 | 4-(Dimethylamino)-1-hexylpyridinium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −1.57 | 227 | 212 |
87 | 4086-73-1 | 1-Octylpyridinium chloride | −1.59 | 228 | 188 |
88 | None (2013-09-19) | 1,3-Dipentylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −1.74 | ||
89 | 1241842-28-3 | 1-[2-[1-(1,3-Benzodioxol-5-yl)-2-butoxy-2-oxoethoxy]-2-oxoethyl]-3-methylimidazolium bromide | −1.96 | ||
90 | 1241839-96-2 | 1-[2-[1-(1,3-Benzodioxol-5-yl)-2-methoxy-2-oxoethoxy]-2-oxoethyl]pyridinium bromide | −2.13 | ||
91 | 425382-14-5 | 1-Heptyl-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −2.13 | ||
92 | 85100-78-3 | 1-Hexyl-3-methylimidazolium bromide | −2.43 | ||
93 | 244193-55-3 | 1-Methyl-3-nonylimidazolium tetrafluoroborate | −2.57 | 217 | 192 |
94 | 382150-50-7 | 1-Hexyl-3-methylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −2.86 | 191 | 71 |
95 | 872672-72-5 | 3-Methyl-1-octylpyridinium bromide | −3.56 | ||
96 | 244193-56-4 | 1-Decyl-3-methylimidazolium tetrafluoroborate | −3.56 | 233 | 205 |
97 | 878005-11-9 | 1-Ethyl-3-methylimidazolium trifluorotris(pentafluoroethyl)phosphate | −3.60 | 226 | 43 |
98 | 178631-04-4 | 1-Methyl-3-octylimidazolium 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide | −3.75 | 210 | 81 |
99 | 61545-99-1 | 1-Methyl-3-octylimidazolium bromide | −3.93 | ||
100 | None (2013-09-19) | 1-(11-Ethoxy-11-oxoundecyl)-3-methylimidazolium bromide | −3.93 | ||
101 | 171058-19-8 | 1-Methyl-3-octadecylimidazolium chloride | −4.76 | 242 | 209 |
102 | 244193-52-0 | 1-Methyl-3-octylimidazolium tetrafluoroborate | −5.32 | 219 | 186 |
103 | 61546-01-8 | 1-Hexadecyl-3-methylimidazolium chloride | −5.99 | 244 | 220 |
104 | 171058-21-2 | 1-Methyl-3-tetradecylimidazolium chloride | −6.90 | 245 | 225 |
The procedure adopted here to derive the above toxicity scores is not new and it is analogous to that already adopted to parameterise discrete variables (solvent, catalyst, etc.) by means of the so-called “principal properties” (PP), quantitative descriptors presently available for Lewis acids,21 amines,21 ketones,21 aromatic substituents,22 amino acids,23–25 heteroaromatics,26,27 solvents21,28 and lanthanide triflates.29 PPs are the scores of a PCA analysis applied to a data matrix containing a series of experimental observations (variables) for a set of chemical structures (objects) and are suitable for experimental design as they are orthogonal to each other. Other advantages are that they can be determined for a larger set of objects with respect to those available for single observables in the matrix and are affected by lower errors as compared to those of the single observables determinations as PCA derives them exploiting similar information content provided by the original variables. It is worth mentioning here that no single aquatic toxicity test is available for such a high number of ILs (104) and that this result could be achieved by applying multivariate data analysis to six different tests, each available for a lower number of ILs.
The first PC scores, which can be defined as “toxicity towards fungi and bacteria scores” for all the examined 87 ILs are reported in Table 2 in order of decreasing t1 values, i.e. of increasing toxicity. It is worth mentioning that none of the 26 fungi and bacteria toxicities in the matrix was available for as many as 87 ILs and that the above scores are affected by lower errors as compared to single toxicity determinations and comprise information provided by both Gram-positive and Gram-negative bacteria as well as by fungi.
CAS no. | Name | t1 bacteria and fungi toxicity model | |
---|---|---|---|
1 | 126049-85-2 | 1,3-Bis(propoxymethyl)imidazolium chloride | 4.96 |
2 | 761410-60-0 | 1,3-Bis(butoxymethyl)imidazolium chloride | 4.81 |
3 | 885224-26-0 | 1-Hexylimidazolium (2S)-2-hydroxypropanoate | 4.78 |
4 | 615538-92-6 | 1-Methylimidazolium 2-hydroxypropanoate | 4.64 |
5 | 1010075-76-9 | 1-Methylimidazolium (2S)-2-hydroxypropanoate | 4.64 |
6 | 615538-93-7 | 1-Ethylimidazolium 2-hydroxypropanoate | 4.64 |
7 | None (2013-09-19) | 1-Ethylimidazolium (2S)-2-hydroxypropanoate | 4.64 |
8 | 615538-94-8 | 1-Propylimidazolium 2-hydroxypropanoate | 4.64 |
9 | 615538-96-0 | 1-Pentylimidazolium 2-hydroxypropanoate | 4.64 |
10 | None (2013-09-19) | 1-Pentylimidazolium (2S)-2-hydroxypropanoate | 4.64 |
11 | None (2013-09-19) | 1-Propylimidazolium (2S)-2-hydroxypropanoate | 4.62 |
12 | 885224-25-9 | 1-Butylimidazolium (2S)-2-hydroxypropanoate | 4.54 |
13 | 615539-04-3 | 1-(Butoxymethyl)imidazolium 2-hydroxypropanoate | 4.53 |
14 | 885224-28-2 | 1-(Butoxymethyl)imidazolium (2S)-2-hydroxypropanoate | 4.53 |
15 | 761410-61-1 | 1,3-Bis[(pentyloxy)methyl]imidazolium chloride | 4.47 |
16 | None (2013-09-19) | 1-[(Pentyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | 4.34 |
17 | 615538-97-1 | 1-Hexylimidazolium 2-hydroxypropanoate | 4.32 |
18 | 615539-05-4 | 1-[(Pentyloxy)methyl]imidazolium 2-hydroxypropanoate | 4.11 |
19 | 615538-98-2 | 1-Heptylimidazolium 2-hydroxypropanoate | 4.08 |
20 | None (2013-09-19) | 1,3-Bis[(tetradecyloxy)methyl]imidazolium chloride | 3.76 |
21 | None (2013-09-19) | 1,3-Bis[(hexadecyloxy)methyl]imidazolium chloride | 3.76 |
22 | 885224-29-3 | 1-[(Hexyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | 3.51 |
23 | None (2013-09-19) | 1-Heptylimidazolium (2S)-2-hydroxypropanoate | 3.47 |
24 | 435346-40-0 | 3-(Aminocarbonyl)-1-[(cyclododecyloxy)methyl]pyridinium chloride | 2.97 |
25 | 615539-06-5 | 1-[(Hexyloxy)methyl]imidazolium 2-hydroxypropanoate | 2.87 |
26 | 97166-40-0 | 1-[(Octyloxy)methyl]quinolinium chloride | 2.74 |
27 | 761410-68-8 | 1,3-Bis[(dodecyloxy)methyl]imidazolium chloride | 2.64 |
28 | 97166-39-7 | 1-[(Hexyloxy)methyl]quinolinium chloride | 2.52 |
29 | 615539-07-6 | 1-[(Heptyloxy)methyl]imidazolium 2-hydroxypropanoate | 1.94 |
30 | 13501-50-3 | 1-[(Decyloxy)methyl]quinolinium chloride | 1.87 |
31 | 761410-67-7 | 1,3-Bis[(undecyloxy)methyl]imidazolium chloride | 1.57 |
32 | None (2013-09-19) | 1-[(Heptyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | 1.36 |
33 | 898558-87-7 | 1-Octylimidazolium (2S)-2-hydroxypropanoate | 1.31 |
34 | 41063-22-3 | 1-[(Dodecyloxy)methyl]quinolinium chloride | 1.28 |
35 | 435346-42-2 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium iodide | 0.91 |
36 | 435346-66-0 | 3-[[[[(Decyloxy)methoxy]methyl]amino]carbonyl]-1-[(decyloxy)methyl]pyridinium chloride | 0.82 |
37 | 615538-99-3 | 1-Octylimidazolium 2-hydroxypropanoate | 0.76 |
38 | 435346-76-2 | 4-(Aminocarbonyl)-1-[(decyloxy)methyl]pyridinium chloride | 0.48 |
39 | 435346-52-4 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium tetrafluoroborate | 0.29 |
40 | 97166-41-1 | 1-[(Hexyloxy)methyl]-6-methylquinolinium chloride | 0.25 |
41 | 435346-34-2 | 3-(Aminocarbonyl)-1-[(decyloxy)methyl]pyridinium chloride | 0.10 |
42 | 615539-08-7 | 1-[(Octyloxy)methyl]imidazolium 2-hydroxypropanoate | −0.47 |
43 | 761410-62-2 | 1,3-Bis[(hexyloxy)methyl]imidazolium chloride | −0.52 |
44 | 435346-77-3 | 4-(Aminocarbonyl)-1-[(undecyloxy)methyl]pyridinium chloride | −0.81 |
45 | 898558-90-2 | 1-[(Octyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | −0.92 |
46 | 435346-45-5 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium perchlorate | −0.94 |
47 | 615539-10-1 | 1-[(Decyloxy)methyl]imidazolium 2-hydroxypropanoate | −1.36 |
48 | 435346-35-3 | 3-(Aminocarbonyl)-1-[(undecyloxy)methyl]pyridinium chloride | −1.42 |
49 | 435346-36-4 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium chloride | −1.51 |
50 | 761410-66-6 | 1,3-Bis[(decyloxy)methyl]imidazolium chloride | −1.59 |
51 | 615539-09-8 | 1-[(Nonyloxy)methyl]imidazolium 2-hydroxypropanoate | −1.60 |
52 | 97166-48-8 | 1-[(Dodecyloxy)methyl]-8-hydroxyquinolinium chloride | −1.67 |
53 | 435346-44-4 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium nitrate | −1.75 |
54 | 435346-41-1 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium bromide | −1.97 |
55 | 97166-46-6 | 8-Hydroxy-1-[(octyloxy)methyl]quinolinium chloride | −2.03 |
56 | 97166-45-5 | 1-[(Hexyloxy)methyl]-8-hydroxyquinolinium chloride | −2.24 |
57 | 435346-55-7 | Bis[3-(aminocarbonyl)-1-[(decyloxy)methyl]pyridinium] (T-4)-tetrachlorocuprate | −2.28 |
58 | 435346-53-5 | 3-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium acetate | −2.43 |
59 | 435346-56-8 | Bis[3-(aminocarbonyl)-1-[(decyloxy)methyl]pyridinium] (T-4)-tetrachlorozincate | −2.47 |
60 | 97166-42-2 | 6-Methyl-1-[(octyloxy)methyl]quinolinium chloride | −2.58 |
61 | 615539-00-9 | 1-Nonylimidazolium 2-hydroxypropanoate | −2,61 |
62 | 435346-58-0 | 3-(Aminocarbonyl)-1-[(decyloxy)methyl]pyridinium (T-4)-tetrachloroferrate | −2.69 |
63 | 898558-88-8 | 1-Nonylimidazolium (2S)-2-hydroxypropanoate | −2.91 |
64 | 615539-12-3 | 1-[(Dodecyloxy)methyl]imidazolium 2-hydroxypropanoate | −3.14 |
65 | 435346-78-4 | 4-(Aminocarbonyl)-1-[(dodecyloxy)methyl]pyridinium chloride | −3.34 |
66 | 435346-54-6 | Bis[3-(aminocarbonyl)-1-[(decyloxy)methyl]pyridinium] (T-4)-tetrachlorocobaltate | −3.38 |
67 | 898558-91-3 | 1-[(Nonyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | −3.51 |
68 | 97166-47-7 | 1-[(Decyloxy)methyl]-8-hydroxyquinolinium chloride | −3.52 |
69 | 97166-44-4 | 1-[(Dodecyloxy)methyl]-6-methylquinolinium chloride | −3.52 |
70 | 615539-11-2 | 1-[(Undecyloxy)methyl]imidazolium 2-hydroxypropanoate | −3.66 |
71 | 435346-57-9 | Bis[3-(aminocarbonyl)-1-[(decyloxy)methyl]pyridinium] (T-4)-tetrachloromagnesate | −4.18 |
72 | 615539-03-2 | 1-Dodecylimidazolium 2-hydroxypropanoate | −4.31 |
73 | 435346-65-9 | 3-[[[[(Nonyloxy)methoxy]methyl]amino]carbonyl]-1-[(nonyloxy)methyl]pyridinium chloride | −4.41 |
74 | 435346-63-7 | 3-[[[[(Heptyloxy)methoxy]methyl]amino]carbonyl]-1-[(heptyloxy)methyl]pyridinium chloride | −4.53 |
75 | 615539-01-0 | 1-Decylimidazolium 2-hydroxypropanoate | −4.69 |
76 | 615539-02-1 | 1-Undecylimidazolium 2-hydroxypropanoate | −4.74 |
77 | 885224-30-6 | 1-[(Decyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | −5.14 |
78 | 435346-64-8 | 3-[[[[(Octyloxy)methoxy]methyl]amino]carbonyl]-1-[(octyloxy)methyl]pyridinium chloride | −5.44 |
79 | 898558-92-4 | 1-[(Dodecyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | −5.81 |
80 | 761410-65-5 | 1,3-Bis[(nonyloxy)methyl]imidazolium chloride | −5.82 |
81 | 898223-27-3 | 1-Decylimidazolium (2S)-2-hydroxypropanoate | −5.89 |
82 | None (2013-09-19) | 1-[(Undecyloxy)methyl]imidazolium (2S)-2-hydroxypropanoate | −5.90 |
83 | 761410-64-4 | 1,3-Bis[(octyloxy)methyl]imidazolium chloride | −5.92 |
84 | 97166-43-3 | 1-[(Decyloxy)methyl]-6-methylquinolinium chloride | −6.04 |
85 | 761410-63-3 | 1,3-Bis[(heptyloxy)methyl]imidazolium chloride | −6.54 |
86 | 885224-27-1 | 1-Undecylimidazolium (2S)-2-hydroxypropanoate | −6.93 |
87 | 898558-89-9 | 1-Dodecylimidazolium (2S)-2-hydroxypropanoate | −7.03 |
In order to achieve a deeper insight into the effect of anions, PCA was limited to imidazolium cations (a data matrix with 218 ILs and 43 biological and degradation tests). In this case PCA provided a 3PC model explaining 85% of total variance (Q2 = 0.706) with the 1st PC explaining already 66% of variance (Q2 = 0.594).
In the t1–t2 scores plot reported in Fig. 7, where ILs are coloured according to the anion, no clustering of anions can be observed, pointing out that the anion has not a key role in addressing the ILs toxicity, which appears more significantly affected by the chemical structure of the imidazolium substituents. These effects can be better evidenced by carrying out a PCA on a data matrix including only ILs with the same cation scaffold (imidazolium) and the same anion (chloride). This data matrix contains 37 ILs and 24 biological and degradation tests. The t1–t2 scores plot (Fig. 8) shows in the right part of the plot (less toxic compounds according to superimposition with the p1–p2 loadings reported in Fig. 9) ILs with short alkyl side chains and dialkyloxyethers with short (2–5) and long (11–14) carbon alkyl chains, whereas ILs with long alkyl side chains and dialkyloxyethers with medium length (7–10 carbon atoms) can be found in the left part of the plot (toxic compounds). The higher toxicity of alkylimidazolium with longer side chains is well known and has been reported in the literature also for pyrrolidinium, piperidinium and pyridinium ILs and related to the higher hydrophobicity of long side chains.20 However, the toxicity “levelled off on reaching a threshold side chain length”20 which depends on the IL class. It has also been noted that “the presence of oxygen in the side chain seems to decrease the toxicity”.20 Pernak et al.30 reported that mono alkyloxyether imidazoliums exhibit a maximum of toxicity (microbial toxicity) for dodecyloxymethyl imidazolium (12 carbon atom side chain), while a toxicity decrease was observed up to 16 carbon atoms side chains. Garcia et al.31 recently reported an analogous behavior for monoalkylesters imidazolium and pyridinium ILs. They noted that an increase of the carbon atoms in the ester side chain resulted in a higher tendency to form micellar aggregates. In this context we can observe (Fig. 8) high toxicity of dialkyloxyether imidazoliums for ILs having 7–9 carbon atoms in each side chain. The decrease of toxicity observed for dialkyloxyethers ILs with more than 12 carbon atoms in each side chain may be ascribed to the formation of micellar aggregates, which avoid the interaction of the ILs with the cell membrane.31 Therefore toxicity might be due to a balance of hydrophobicity and formation of micelles. The above toxicity trend found for the overall imidazolium model has been confirmed in the case of more specific models which consider separately toxicity towards aquatic organisms and towards fungi and bacteria. (Fig. S9 and S10 in ESI‡).
In Tables S5 and S6‡ we report respectively the log of IPC-81 rat cell lines growth inhibition, and AChE enzyme inhibition ordered according to decreasing values, i.e. of increasing toxicity. Fig. 10a shows no correlation between the latter toxicity measurements, as expected on the basis of the biological differences in these toxicity “sensors”. It is worth to comment also correlations between the t1 scores of the aquatic ecotoxicity model and IPC-81 and AChE values plotted in Fig. 10b and c. No correlation can be observed with the enzymatic activity (Fig. 10b), while a correlation with IPC-81 can be envisaged (Fig. 10c). The latter correlation provides an answer to the question whether “a negative impact on water” may be “caused by the same structures as the ones that were showed to be harsher to rat cell lines”.18 In fact the impact of aquatic ecotoxicity is found to be paralleled by an effect on the cellular response in living organisms such as IPC-81 rat cell lines. IPC-81 and AChE toxicity values are not available for most ILs tested with fungi and bacteria, therefore no correlation can be attempted with t1 scores of this model.
Table 1 reports the ILs according to the aquatic toxicity t1 “scores” together with the rank of the same ILs in Tables S5 (logIPC-81 rat cell lines growth inhibition) and S6‡ (log
AChE enzyme inhibition) respectively. According to three out of the four toxicities considered in the present work, compounds n. 2, 4, 7, 8, 12, 17 and 20 (Chart 1) can be recommended as safe ILs, while the use of 86, 87, 93, 96, 101, 103 and 104 (Chart 2) should be discouraged or limited, provided that appropriate actions are taken, to cases in which no task specific applicative alternatives are available. The latter ILs should be assigned priority in more extensive (and more expensive) toxicological studies. Guidance on the choice of less toxic ILs according to fungi and bacteria ecotoxicity (the fourth kind of toxicity considered in the present work) can be obtained from Table 2. Inspection of both Tables 1 and 2 is necessary to obtain information about ILs toxicity, as it was not possible to summarize available toxicity information using a unique toxicity score, due to the lack of data which can be ascribed to different ILs hydrophilic/hydrophobic properties preventing their determination in different biological “sensors”. However, the above tables provide a simplified picture of scattered toxicity data available in the literature very useful for the new EU chemical legislation for the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) adopted in June 2007.
(1) Derivation of consistent toxicity “scores” for aquatic and bacteria and fungi toxicities (now available for an unprecedented significant number of ILs) summarizing toxicity information available from a huge amount of scattered literature data regarding specific biological “sensors”.
(2) Estimation of quantitative relationships among different toxicities evidencing a correlation between aquatic ecotoxicity and the response of IPC-81 rat cell lines.
(3) Confirmation of the effects of cation structural features such as the increase of ILs toxicity on increasing the length of the side chain, its decrease when oxygen atoms are present in the side chain, and the presence of a maximum of toxicity for a given side chain length depending on the specific cationic moiety, which may be ascribed to the formation of micellar aggregates.
Evaluation of the negative impact of ILs on water and soil, as well as on rat and human cell lines, is a complicated task. The present work, providing a comprehensive picture and guidelines for the evaluation of ILs toxicity, paves the way towards a rational selection of eco-sustainable ILs for specific applications. Of course the destination is far from being reached. However, a better knowledge on the quantitative relationships between the chemical structures of ILs, their physicochemical properties, and their biological activities would move a step forward in the right direction. Investigations in this context are in progress in our laboratories.
The data were pre-processed by autoscaling all variables to unitary variance, i.e. by multiplying the variables by appropriate weights (the reciprocal of the variable standard deviation) to give them unit variance (i.e. the same importance). Autoscaled matrix elements were then fitted into a model given by eqn (1), where the number A of significant cross terms (components), and the parameters pak and tia are calculated by minimising the residuals eik, after subtracting k (the mean value of the ith experimental quantities xk).
![]() | (1) |
Parameters k and pak (the loadings) depend only on the variables, and the tia (scores) only on the objects. The deviations from the model are expressed by the residuals eik. The number of significant components (A) was determined using the cross-validation (CV) technique.33 CV was performed by dividing the data into a number of groups (five to nine) and then developing a number of parallel models from reduced data with one of the groups deleted. The performance of the model can be evaluated by two parameters: R2 related to the goodness of fit and Q2 to the goodness of prediction.
Footnotes |
† Dedicated in memoriam to Professor Alan R. Katritzky (1928–2014), a worldwide recognised leader of heterocyclic chemistry. |
‡ Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ra03230f |
This journal is © The Royal Society of Chemistry 2014 |